GlassScriptPhysician profile
Jeffrey J Garner
NPI 1467686303
$14,215.43
in general payments reported to CMS, 2019-2025
42 companies · $3,347 in 2025
The $3,347 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,854 · 2020: $1,011 · 2021: $781 · 2022: $1,319 · 2023: $1,482 · 2024: $4,421 · 2025: $3,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,868 · Education: $3,000 · Travel and Lodging: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,868.04 |
| Education | $3,000.00 |
| Travel and Lodging | $1,382.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,450.11 | 2024-2025 | |
| Glaxosmithkline, LLC. | $2,094.28 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,042.86 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $826.87 | 2019-2025 | Ofev |
| Mallinckrodt Hospital Products INC. | $766.30 | 2020-2025 | Acthar, Terlivaz |
| Regeneron Healthcare Solutions, INC. | $608.62 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $540.08 | 2019-2024 | Prolastin-C Liquid |
| Genentech USA, INC. | $412.99 | 2019-2020 | |
| Amgen INC. | $312.11 | 2022-2025 | Tezspire |
| Philips North America LLC | $296.55 | 2019-2024 | (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $284.51 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Takeda Pharmaceuticals U.S.A., INC. | $270.65 | 2020-2025 | Glassia |
| Gilead Sciences, INC. | $235.62 | 2021-2023 | |
| Csl Behring | $221.23 | 2021-2024 | Hizentra |
| United Therapeutics Corporation | $212.36 | 2019-2025 | Tyvaso, Tyvaso |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $177.18 | 2019-2024 | Yupelri |
| Insmed, INC. | $173.48 | 2019-2025 | Brinsupri, Arikayce |
| Genzyme Corporation | $131.98 | 2020-2025 | |
| Mallinckrodt Enterprises LLC | $121.82 | 2019 | |
| Vifor Pharma, INC. | $111.02 | 2024-2025 | Zemaira |
| Ethicon INC. | $107.42 | 2023-2025 | Monarch Platform |
| Ani Pharmaceuticals, INC. | $91.17 | 2022-2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $83.50 | 2019-2021 | |
| Astellas Pharma US INC | $70.88 | 2022-2024 | Cresemba |
| Pfizer INC. | $69.65 | 2019-2024 | |
| Inogen, INC. | $62.34 | 2022-2024 | Inogen At Home Stationary Concentrator |
| Harmony Biosciences LLC | $49.43 | 2023-2025 | Wakix |
| Janssen Pharmaceuticals, INC | $48.44 | 2019-2022 | |
| Varian Medical Systems, INC. | $46.62 | 2019 | |
| Pulmonx Corporation | $43.50 | 2023-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Axsome Therapeutics, INC. | $34.47 | 2023-2025 | Sunosi |
| Electromed, INC. | $32.59 | 2022-2023 | Smartvest |
| Avanos Medical | $30.99 | 2019 | |
| Cook Medical LLC | $22.83 | 2019-2020 | |
| Viatris Specialty LLC | $21.88 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $17.97 | 2022 | |
| Baxter Healthcare | $17.58 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $17.27 | 2023 | |
| Shionogi INC | $15.03 | 2023 | Fetroja |
| 3b Medical, INC. | $14.33 | 2023 | Luna |
| Sunovion Pharmaceuticals INC. | $14.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.